Decoys for treating and/or preventing th2 cytokine-related allergic diseases, gata3 mutant proteins and, pharmaceutical compositions comprising the decoys and the proteins
CA 2483106 A1 · Owner: Arai, Ken-Ichi · Inventors: Arai, Ken-Ichi; Miyatake, Shoichiro; Takemoto, Naofumi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A GATA3 decoy whereby the production of Th2 cytokine can be specifically inhibited, a GATA3 mutant protein and medicinal compositions containing the same can be provided by inhibiting the binding of GATA3 to the low affinity GATA3-binding sequence occurring in a Th2 cytokine gene cluster and thus inhibiting the chromatin modeling which is necessary for the stable and sufficient expression of Th2 cytokine.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 24, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 24, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 24, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.